Bioptigen Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 25

Employees

  • Latest Deal Type
  • M&A

Bioptigen General Information

Description

Developer and manufacturer of Spectral Domain Optical Coherence Tomography equipment and software. The company's product enables real-time non-invasive two and three dimensional imaging of living subjects with resolution up to 100-times finer than 4D ultrasound techniques.

Contact Information

Website
www.bioptigen.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Post Office Box 13569
  • Durham, NC 27709
  • United States
+1 (919)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Acquirer
Leica Microsystems
Vertical(s)
Manufacturing, SaaS, TMT
Corporate Office
  • Post Office Box 13569
  • Durham, NC 27709
  • United States
+1 (919)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioptigen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 08-Jun-2015 Completed Generating Revenue
9. Grant 29-Sep-2014 Completed Generating Revenue
8. Debt - General 01-Jan-2014 Completed Generating Revenue
7. Grant 06-Oct-2011 Completed Generating Revenue
6. Early Stage VC 03-Mar-2011 Completed Generating Revenue
5. Angel (individual) 01-Jan-2009 Completed Startup
4. Angel (individual) 01-Jan-2008 Completed Startup
3. Early Stage VC 13-Sep-2007 Completed Startup
2. Early Stage VC (Series A) 12-Sep-2006 $1.3M $1.32M Completed Startup
1. Debt - General 01-Jan-2005 $17.6K $17.6K Completed Startup
To view Bioptigen’s complete valuation and funding history, request access »

Bioptigen Patents

  • 96

    Total Documents Applications and Grants

  • Total Patents Families

  • 58

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Bioptigen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170131533-A1 Illumination field diaphragms for use in microscopes and related methods and systems Active 09-Nov-2015
US-10409046-B2 Illumination field diaphragms for use in microscopes and related methods and systems Active 09-Nov-2015
JP-2019504334-A Illumination field stop and related methods and systems for use in a microscope Active 09-Nov-2015
JP-6639668-B2 Illumination field stop for use in a microscope and related methods and systems Active 09-Nov-2015
EP-3373796-B1 Systems with illumination field diaphragms Active 09-Nov-2015 G02B21/0012
To view Bioptigen’s complete patent history, request access »

Bioptigen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioptigen Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ariel Savannah Angel Partners Angel Group Minority
BlueTree Allied Angels Angel Group Minority
Piedmont Angel Network Angel Group Minority
Southeast TechInventures Accelerator/Incubator Minority
Westlake Ventures (St. Petersburg) Venture Capital Minority
To view Bioptigen’s complete investors history, request access »

Ready to get started?

Request a free trial

Bioptigen FAQs

  • When was Bioptigen founded?

    Bioptigen was founded in 2004.

  • Where is Bioptigen headquartered?

    Bioptigen is headquartered in Durham, NC.

  • What is the size of Bioptigen?

    Bioptigen has 25 total employees.

  • What industry is Bioptigen in?

    Bioptigen’s primary industry is Diagnostic Equipment.

  • Is Bioptigen a private or public company?

    Bioptigen is a Private company.

  • What is Bioptigen’s current revenue?

    The current revenue for Bioptigen is .

  • How much funding has Bioptigen raised over time?

    Bioptigen has raised $3.82M.

  • Who are Bioptigen’s investors?

    Ariel Savannah Angel Partners, BlueTree Allied Angels, Piedmont Angel Network, Southeast TechInventures, and Westlake Ventures (St. Petersburg) have invested in Bioptigen.

  • When was Bioptigen acquired?

    Bioptigen was acquired on 08-Jun-2015.

  • Who acquired Bioptigen?

    Bioptigen was acquired by Leica Microsystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »